TURNER DANIEL K III 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 4, 2010
Insider Transaction Report
Form 4
TURNER DANIEL K III
Director
Transactions
- Award
Common Stock Option (right to buy)
2010-02-03+1,900→ 1,900 totalExercise: $8.07Exp: 2020-02-03→ Common Stock (1,900 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments beginning on March 3, 2010.